Last Updated on November 11, 2024 by The Health Master
Zydus Lifesciences has announced that the group’s injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, underwent USFDA inspection from 5th June to 13 June, 2023.
The cGMP inspection concluded with nil observations
This signifies that the facility has met the standards set by the current Good Manufacturing Practices (GMP).
The GMP ensures that manufacturing processes and facilities are designed, monitored, and controlled effectively, guaranteeing the production of safe and effective products that meet quality standards.
Understanding GMP, cGMP, and WHO-GMP
USFDA completes inspection of Dr Reddy’s with zero observation
USFDA issues Form 483 with 11 observations IPCA Labs: Ratlam
USFDA issues Form 483 with 4 observations to Aurobindo Pharma
USFDA issues Form 483 with zero observations to Pharma MSMEs: Gujarat
USFDA issues Form 483 with 3 observation to Zydus, Ahmedabad
USFDA issues Form 483 with zero observation to Piramal
DTAB recommendation: On presence of banned antibiotics in food producing animals
Codeine cough syrup worth Rs 35 lakh seized: Maharashtra
DTAB: Proposal to Amend Medical Devices Rules for Hospital Imports
Guidance documents for industry
USFDA completes inspection of Dr Reddy’s with zero observation
PCI and IPA join hands to enhance quality of Pharmacy Education
USFDA issues Form 483 with 11 observations IPCA Labs: Ratlam
UP Govt Drafts Pharmaceutical Industry Policy 2023: Details
Safe Disposal of Unused Drugs: Urgent Need a Comprehensive Policy
Drug alert: 28 out of 1302 samples declared as NSQ in May 2023
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
